Hong Kong stocksIPO

Hengrui Pharma’s HK$9.89 Billion IPO: A Strategic Move to Cement Global Pharmaceutical Leadership

Minichart
May 18, 2025

IPO Details Purpose of IPO: Hengrui Pharma aims to ra...

Continue Reading 0